Your browser doesn't support javascript.
loading
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.
Zhao, Fangzhu; Yuan, Meng; Keating, Celina; Shaabani, Namir; Limbo, Oliver; Joyce, Collin; Woehl, Jordan; Barman, Shawn; Burns, Alison; Tran, Quoc; Zhu, Xueyong; Ricciardi, Michael; Peng, Linghang; Smith, Jessica; Huang, Deli; Briney, Bryan; Sok, Devin; Nemazee, David; Teijaro, John R; Wilson, Ian A; Burton, Dennis R; Jardine, Joseph G.
Afiliación
  • Zhao F; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Yuan M; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Keating C; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
  • Shaabani N; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Limbo O; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Joyce C; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Woehl J; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
  • Barman S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Burns A; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Tran Q; IAVI, New York, NY 10004, USA.
  • Zhu X; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Ricciardi M; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Peng L; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
  • Smith J; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Huang D; IAVI, New York, NY 10004, USA.
  • Briney B; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Sok D; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Nemazee D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
  • Teijaro JR; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Wilson IA; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Burton DR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
  • Jardine JG; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
Sci Signal ; 16(798): eabk3516, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37582161
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos